1
de Wijs, L. E.M., Joustra, M. M., Olydam, J. I., Nijsten, T., Hijnen, D. J.
Veröffentlicht in: de Wijs , L E M , Joustra , M M , Olydam , J I , Nijsten , T & Hijnen , D J 2021 , ' COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands : real-world observational data ' , Journal of the European Academy of Dermatology and Venereology , vol. 35 , no. 3 , pp. e173-e176 . https://doi.org/10.1111/jdv.17025;
2021
Veröffentlicht in: de Wijs , L E M , Joustra , M M , Olydam , J I , Nijsten , T & Hijnen , D J 2021 , ' COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands : real-world observational data ' , Journal of the European Academy of Dermatology and Venereology , vol. 35 , no. 3 , pp. e173-e176 . https://doi.org/10.1111/jdv.17025;
2021
2
3
de Wijs, L. E.M., Fujimoto, R. F.T., Andrinopoulou, E. R., Nijsten, T., Hijnen, D., Kataoka, Y.
Veröffentlicht in: de Wijs , L E M , Fujimoto , R F T , Andrinopoulou , E R , Nijsten , T , Hijnen , D & Kataoka , Y 2021 , ' Dupilumab treatment in patients with atopic dermatitis : a comparative cohort study between the Netherlands and Japan shows a discrepancy in patient-reported outcome measures ' , British Journal of Dermatology , vol. 185 , no. 3 , pp. 555-562 . https://doi.org/10.1111/bjd.19897;
2021
Veröffentlicht in: de Wijs , L E M , Fujimoto , R F T , Andrinopoulou , E R , Nijsten , T , Hijnen , D & Kataoka , Y 2021 , ' Dupilumab treatment in patients with atopic dermatitis : a comparative cohort study between the Netherlands and Japan shows a discrepancy in patient-reported outcome measures ' , British Journal of Dermatology , vol. 185 , no. 3 , pp. 555-562 . https://doi.org/10.1111/bjd.19897;
2021
4
5